Antiplatelet and Anti-proliferative Action of Disintegrin from Echis Multisquamatis Snake Venom

Overview

Journal Croat Med J

Specialty General Medicine

Date 2017 Apr 15

PMID 28409495

Citations 5

Authors

Volodymyr Chernyshenko

Natalia Petruk

Darya Korolova

Ludmila Kasatkina

Olha Gornytska

Tetyana Platonova

Tamara Chernyshenko

Andriy Rebriev

Olena Dzhus

Liudmyla Garmanchuk

Eduard Lugovskoy

Affiliations

Soon will be listed here.

Abstract

Aim: To purify the platelet aggregation inhibitor from Echis multisquamatis snake venom (PAIEM) and characterize its effect on platelet aggregation and HeLa cell proliferation.

Methods: Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and matrix assisted laser desorption/ionization time-of-flight (MALDI-TOF) were used for PAIEM identification. Platelet aggregation in the presence of PAIEM was studied on aggregometer Solar-AP2110. The changes of shape and granularity of platelets in the presence of PAIEM were studied on flow cytometer COULTER EPICS XL, and degranulation of platelets was estimated using spectrofluorimetry. Indirect enzyme-linked immunosorbent assay was used for the determination of target of PAIEM on platelet surface. An assay based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide was used to evaluate the effect of PAIEM on the proliferation of HeLa cells in cell culture.

Results: The molecular weight of the protein purified from Echis multisquamatis venom was 14.9 kDa. Half-maximal inhibitory concentration (IC50) of PAIEM needed to inhibit adenosine diphosphate (ADP)-induced platelet aggregation was 7 μM. PAIEM did not affect thrombin- or ADP-induced platelet activation, but it did prevent binding of the anti-IIb antibody to glycoprotein IIb/IIIa (GPIIbIIIa)-receptor of adhered platelets and inhibited the viability of HeLa cells by 54%.

Conclusion: As a member of the disintegrin family, PAIEM inhibited platelet aggregation and cell proliferation possibly by blocking integrin-mediated interactions. However, it did not impair cellular signaling causing any changes in platelet shape and granularity and did not affect ADP-induced platelet degranulation. This disintegrin was shown to be a potent inhibitor of integrin-mediated cellular interactions including platelet aggregation or cancer cell proliferation.

Citing Articles

Bibliometric Analysis of Literature in Snake Venom-Related Research Worldwide (1933-2022).

Sofyantoro F, Yudha D, Lischer K, Nuringtyas T, Putri W, Kusuma W Animals (Basel). 2022; 12(16).

PMID: 36009648 PMC: 9405337. DOI: 10.3390/ani12162058.

Reptiles as Promising Sources of Medicinal Natural Products for Cancer Therapeutic Drugs.

Park S, Choi H, Chung J Pharmaceutics. 2022; 14(4).

PMID: 35456708 PMC: 9025323. DOI: 10.3390/pharmaceutics14040874.

Snake Venom Components: Tools and Cures to Target Cardiovascular Diseases.

Frangieh J, Rima M, Fajloun Z, Henrion D, Sabatier J, Legros C Molecules. 2021; 26(8).

PMID: 33921462 PMC: 8070158. DOI: 10.3390/molecules26082223.

Exogenous Integrin αIIbβ3 Inhibitors Revisited: Past, Present and Future Applications.

van den Kerkhof D, van der Meijden P, Hackeng T, Dijkgraaf I Int J Mol Sci. 2021; 22(7).

PMID: 33806083 PMC: 8036306. DOI: 10.3390/ijms22073366.

Cytotoxic and anticancer properties of the Malaysian mangrove pit viper () venom and its disintegrin (purpureomaculin).

Tan C, Liew J, Navanesan S, Sim K, Tan N, Tan K J Venom Anim Toxins Incl Trop Dis. 2020; 26:e20200013.

PMID: 32742279 PMC: 7375409. DOI: 10.1590/1678-9199-JVATITD-2020-0013.

References

Wijeyeratne Y, Heptinstall S . Anti-platelet therapy: ADP receptor antagonists. Br J Clin Pharmacol. 2011; 72(4):647-57. PMC: 3187865. DOI: 10.1111/j.1365-2125.2011.03999.x. View

Konokhova A, Yurkin M, Moskalensky A, Chernyshev A, Tsvetovskaya G, Chikova E . Light-scattering flow cytometry for identification and characterization of blood microparticles. J Biomed Opt. 2012; 17(5):057006. DOI: 10.1117/1.JBO.17.5.057006. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Gao W, Chen S, Wu M, Gao K, Li Y, Wang H . Methylprednisolone exerts neuroprotective effects by regulating autophagy and apoptosis. Neural Regen Res. 2016; 11(5):823-8. PMC: 4904476. DOI: 10.4103/1673-5374.182711. View

Marcinkiewicz C, Lobb R, Marcinkiewicz M, Daniel J, Smith J, Dangelmaier C . Isolation and characterization of EMS16, a C-lectin type protein from Echis multisquamatus venom, a potent and selective inhibitor of the alpha2beta1 integrin. Biochemistry. 2000; 39(32):9859-67. DOI: 10.1021/bi000428a. View

Fontana P, Zufferey A, Daali Y, Reny J . Antiplatelet therapy: targeting the TxA2 pathway. J Cardiovasc Transl Res. 2013; 7(1):29-38. DOI: 10.1007/s12265-013-9529-1. View

Horii K, Okuda D, Morita T, Mizuno H . Structural characterization of EMS16, an antagonist of collagen receptor (GPIa/IIa) from the venom of Echis multisquamatus. Biochemistry. 2003; 42(43):12497-502. DOI: 10.1021/bi034890h. View

Zeymer U, Wienbergen H . A review of clinical trials with eptifibatide in cardiology. Cardiovasc Drug Rev. 2007; 25(4):301-15. DOI: 10.1111/j.1527-3466.2007.00022.x. View

Fullard J . The role of the platelet glycoprotein IIb/IIIa in thrombosis and haemostasis. Curr Pharm Des. 2004; 10(14):1567-76. DOI: 10.2174/1381612043384682. View

10.

Gryshchuk V, Galagan N . Silica Nanoparticles Effects on Blood Coagulation Proteins and Platelets. Biochem Res Int. 2016; 2016:2959414. PMC: 4736757. DOI: 10.1155/2016/2959414. View

11.

Okuda D, Horii K, Mizuno H, Morita T . Characterization and preliminary crystallographic studies of EMS16, an antagonist of collagen receptor (GPIa/IIa) from the venom of Echis multisquamatus. J Biochem. 2003; 134(1):19-23. DOI: 10.1093/jb/mvg108. View

12.

Ibbotson T, McGavin J, Goa K . Abciximab: an updated review of its therapeutic use in patients with ischaemic heart disease undergoing percutaneous coronary revascularisation. Drugs. 2003; 63(11):1121-63. DOI: 10.2165/00003495-200363110-00014. View

13.

Asmis L, Tanner F, Sudano I, Luscher T, Camici G . DMSO inhibits human platelet activation through cyclooxygenase-1 inhibition. A novel agent for drug eluting stents?. Biochem Biophys Res Commun. 2009; 391(4):1629-33. DOI: 10.1016/j.bbrc.2009.12.102. View

14.

Schneider D . Anti-platelet therapy: glycoprotein IIb-IIIa antagonists. Br J Clin Pharmacol. 2011; 72(4):672-82. PMC: 3195742. DOI: 10.1111/j.1365-2125.2010.03879.x. View

15.

Gresele P, Momi S, Falcinelli E . Anti-platelet therapy: phosphodiesterase inhibitors. Br J Clin Pharmacol. 2011; 72(4):634-46. PMC: 3195739. DOI: 10.1111/j.1365-2125.2011.04034.x. View

16.

Swenson S, Ramu S, Markland F . Anti-angiogenesis and RGD-containing snake venom disintegrins. Curr Pharm Des. 2007; 13(28):2860-71. DOI: 10.2174/138161207782023793. View

17.

Markland F . Snake venoms and the hemostatic system. Toxicon. 1998; 36(12):1749-800. DOI: 10.1016/s0041-0101(98)00126-3. View

18.

Jackson S . The growing complexity of platelet aggregation. Blood. 2007; 109(12):5087-95. DOI: 10.1182/blood-2006-12-027698. View

19.

Okuda D, Nozaki C, Sekiya F, Morita T . Comparative biochemistry of disintegrins isolated from snake venom: consideration of the taxonomy and geographical distribution of snakes in the genus Echis. J Biochem. 2001; 129(4):615-20. DOI: 10.1093/oxfordjournals.jbchem.a002898. View

20.

Minea R, Swenson S, Costa F, Chen T, Markland F . Development of a novel recombinant disintegrin, contortrostatin, as an effective anti-tumor and anti-angiogenic agent. Pathophysiol Haemost Thromb. 2006; 34(4-5):177-83. DOI: 10.1159/000092419. View